Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research Progress on Helicobacter Pylori Infection and Autoimmune Thyroid Disease

Download as PDF

DOI: 10.23977/medsc.2023.040212 | Downloads: 28 | Views: 563

Author(s)

Ziteng Wang 1, Hong Liu 1, Huanhuan Xiong 1, Licun Zhu 2, Wentao Tan 1, Pengfei Zhang 1, Mengqi Zhao 3

Affiliation(s)

1 Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University, No.10, Tieyi Road, Beijing, China
2 Department of Gastroenterology, Shougang Hospital, Peking University, No.9, Jinyuanzhuang Road, Beijing, China
3 Department of Internal Medicine-Cardiovascular, Beijing Shijitan Hospital, Capital Medical University, No.10, Tieyi Road, Beijing, China

Corresponding Author

Hong Liu

ABSTRACT

In recent years, more and more studies have focused on the extra-digestive manifestations of Helicobacter pylori, and thyroid disease is a current hot spot. It has been confirmed that changes in the structure and composition of intestinal flora are related to the occurrence and development of autoimmune thyroid disease (AITD). When the intestinal flora is unbalanced, Helicobacter pylori colonizes the body through the damaged gut and releases special proteins that have similar amino acid sequences to thyroid antibodies. These proteins also destroy the metabolism of the body through molecular simulation and other mechanisms, attack the autoimmune system, especially the thyroid system, and ultimately lead to AITD. Therefore, Helicobacter pylori may play an important role in the pathogenesis of autoimmune thyroid disease, and this evidence may provide new ways to treat autoimmune thyroid disease.

KEYWORDS

Autoimmune thyroid disease; Intestinal flora; Autoimmune diseases; Hashimoto's thyroiditis; Helicobacter pylori

CITE THIS PAPER

Ziteng Wang, Hong Liu, Huanhuan Xiong, Licun Zhu, Wentao Tan, Pengfei Zhang, Mengqi Zhao, Research Progress on Helicobacter Pylori Infection and Autoimmune Thyroid Disease. MEDS Clinical Medicine (2023) Vol. 4: 75-82. DOI: http://dx.doi.org/10.23977/medsc.2023.040212.

REFERENCES

[1] Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997 Sep;84(3):223-43. doi: 10. 1006/ clin. 1997. 4412. PMID: 9281381.
[2] Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015 Feb; 14(2):174-80. doi: 10.1016/j.autrev.2014.10.016. Epub 2014 Oct 25. PMID: 25461470.
[3] Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J Autoimmun. 2015 Nov; 64:82-90. doi: 10.1016/j.jaut.2015.07.009. Epub 2015 Jul 30. PMID: 26235382; PMCID: PMC4628844.
[4] Ahlman H, Nilsson. The gut as the largest endocrine organ in the body. Ann Oncol. 2001; 12 Suppl 2:S63-8. doi: 10.1093/annonc/12.suppl_2.s63. PMID: 11762354.
[5] Blanchard TG, Czinn SJ. Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease. Pediatr Res. 2017 Jan;81(1-2):170-176. doi: 10.1038/pr.2016.199. Epub 2016 Oct 4. PMID: 27701380.
[6] Fischbach W, Malfertheiner P. Helicobacter Pylori Infection. Dtsch Arztebl Int. 2018 Jun 22; 115(25):429-436. doi: 10.3238/arztebl.2018.0429. PMID: 29999489; PMCID: PMC6056709.
[7] Wang XS, Xu XH, Jiang G, Ling YH, Ye TT, Zhao YW, Li K, Lei YT, Hu HQ, Chen MW, Wang H. Lack of Association Between Helicobacter pylori Infection and the Risk of Thyroid Nodule Types: A Multicenter Case-Control Study in China. Front Cell Infect Microbiol. 2021 Dec 14; 11: 766427. doi: 10.3389/fcimb.2021.766427. PMID: 34970506; PMCID: PMC8713074.
[8] Tytgat GN, Rauws EA. Significance of Campylobacter pylori. Aliment Pharmacol Ther. 1987; 1 Suppl 1:527S-539S. doi: 10.1111/j.1365-2036.1987.tb00662.x. PMID: 2979701.
[9] Biasco G, Miglioli M, Barbara L, Corinaldesi R, di Febo G. Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet. 1989 Dec 9; 2(8676):1403. doi: 10.1016/s0140-6736(89)92021-7. PMID: 2574352.
[10] Beji A, Vincent P, Darchis I, Husson MO, Cortot A, Leclerc H. Evidence of gastritis with several Helicobacter pylori strains. Lancet. 1989 Dec 9; 2(8676):1402-3. doi: 10.1016/s0140-6736(89)92020-5. PMID: 2574351.
[11] Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017 Nov;46(9):773-779. doi: 10.1111/apt.14319. Epub 2017 Sep 11. PMID: 28892184.
[12] Penhale WJ, Young PR. The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin Exp Immunol. 1988 May;72(2):288-92. PMID: 2970354; PMCID: PMC1541533.
[13] Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol. 1988 Nov;19(11):1315-26. doi: 10.1016/s0046-8177(88)80287-9. PMID: 3141260.
[14] Krisch LM, Posselt G, Hammerl P, Wessler S. CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families. Infect Immun. 2016 Aug 19; 84(9):2671-80. doi: 10.1128/IAI.00349-16. PMID: 27382024; PMCID: PMC4995908.
[15] Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996 Jul 11; 335(2):99-107. doi: 10.1056/NEJM199607113350206. PMID: 8649497.
[16] Yang M, Sun B, Li J, Yang B, Xu J, Zhou X, Yu J, Zhang X, Zhang Q, Zhou S, Sun X. Alteration of the intestinal flora may participate in the development of Graves' disease: a study conducted among the Han population in southwest China. Endocr Connect. 2019 Jul;8(7):822-828. doi: 10.1530/EC-19-0001. PMID: 31137015; PMCID: PMC6590206.
[17] Bassi V, Santinelli C, Iengo A, Romano C. Identification of a correlation between Helicobacter pylori infection and Graves' disease. Helicobacter. 2010 Dec; 15(6):558-62. doi: 10.1111/j.1523-5378.2010.00802.x. PMID: 21073613.
[18] Figueiredo CA, Marques CR, Costa Rdos S, da Silva HB, Alcantara-Neves NM. Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol. 2014 May 14; 20(18):5235-43. doi: 10.3748/wjg.v20.i18.5235. PMID: 24833853; PMCID: PMC4017038.
[19] Shi WJ, Liu W, Zhou XY, Ye F, Zhang GX. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis. Thyroid. 2013 Oct;23(10):1294-300. doi: 10. 1089 /thy. 2012.0630. Epub 2013 Sep 11. PMID: 23544831.
[20] Graham DY, Osato MS, Olson CA, Zhang J, Figura N. Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection. Helicobacter. 1998 Sep;3(3):174-8. doi: 10.1046/j.1523-5378.1998.08018.x. PMID: 9731987.
[21] Burch HB, Cooper DS. Management of Graves Disease: A Review. JAMA. 2015 Dec 15; 314(23):2544-54. doi: 10.1001/jama.2015.16535. Erratum in: JAMA. 2016 Feb 9; 315(6):614. PMID: 26670972.
[22] Ramos-Leví AM, Marazuela M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr. 2016 Oct; 63(8):421-9. English, Spanish. doi: 10.1016/j.endonu.2016.04.003. Epub 2016 May 24. PMID: 27234136.
[23] Kristensen B. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls. Dan Med J. 2016 Feb;63(2):B5177. PMID: 26836805.
[24] Choi YM, Kim TY, Kim EY, Jang EK, Jeon MJ, Kim WG, Shong YK, Kim WB. Association between thyroid autoimmunity and Helicobacter pylori infection. Korean J Intern Med. 2017 Mar;32(2):309-313. doi: 10. 3904/ kjim. 2014. 369. Epub 2017 Jan 16. PMID: 28092700; PMCID: PMC5339455.
[25] Ponzetto A, Figura N. A milder phenotype of Graves' disease in recent years in Italy. J Endocrinol Invest. 2017 Feb; 40(2):235. doi: 10.1007/s40618-016-0580-z. Epub 2016 Nov 15. PMID: 27848230.
[26] Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 Jan;91(1):151-75. doi: 10.1152/physrev.00003.2008. PMID: 21248165.
[27] Zhang L, Masetti G, Colucci G, Salvi M, Covelli D, Eckstein A, Kaiser U, Draman MS, Muller I, Ludgate M, Lucini L, Biscarini F. Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy. Sci Rep. 2018 May 30; 8(1):8386. doi: 10.1038/s41598-018-26700-1. PMID: 29849043; PMCID: PMC5976672.
[28] Su X, Yin X, Liu Y, Yan X, Zhang S, Wang X, Lin Z, Zhou X, Gao J, Wang Z, Zhang Q. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid. J Clin Endocrinol Metab. 2020 Nov 1; 105(11):dgaa511. doi: 10.1210/clinem/dgaa511. PMID: 32785703.
[29] Shi WJ, Liu W, Zhou XY, Ye F, Zhang GX. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis. Thyroid. 2013 Oct; 23(10):1294-300. doi: 10.1089/thy. 2012.0630. Epub 2013 Sep 11. PMID: 23544831.
[30] Figura N, Di Cairano G, Moretti E, Iacoponi F, Santucci A, Bernardini G, Gonnelli S, Giordano N, Ponzetto A. Helicobacter pylori Infection and Autoimmune Thyroid Diseases: The Role of Virulent Strains. Antibiotics (Basel). 2019 Dec 30; 9(1):12. doi: 10.3390/antibiotics9010012. PMID: 31906000; PMCID: PMC7167994.
[31] Wang Y, Zhu S, Xu Y, Wang X, Zhu Y. Interaction between gene A-positive Helicobacter pylori and human leukocyte antigen II alleles increase the risk of Graves disease in Chinese Han population: an association study. Gene. 2013 Nov 15; 531(1):84-9. doi: 10.1016/j.gene.2013.07.069. Epub 2013 Aug 15. PMID: 23954255.
[32] Gaur K, Saran RK, Batra VV, Sakhuja P, Mishra PK. Is thyrogastric disease a potential setting for oncogenesis? Gastric adenoneuroendocrine carcinoma arising from Helicobacter pylori-associated atrophic gastritis in a patient with autoimmune thyroiditis. Rom J Morphol Embryol. 2017; 58(4):1491-1496. PMID: 29556646.
[33] Fröhlich E, Wahl R. Microbiota and Thyroid Interaction in Health and Disease. Trends Endocrinol Metab. 2019 Aug;30(8):479-490. doi: 10.1016/j.tem.2019.05.008. Epub 2019 Jun 27. PMID: 31257166.
[34] Virili C, Fallahi P, Antonelli A, Benvenga S, Centanni M. Gut microbiota and Hashimoto's thyroiditis. Rev Endocr Metab Disord. 2018 Dec;19(4):293-300. doi: 10.1007/s11154-018-9467-y. PMID: 30294759.
[35] Chiovato L, Magri F, Carlé A. Hypothyroidism in Context: Where We've Been and Where We're Going. Adv Ther. 2019 Sep; 36(Suppl 2):47-58. doi: 10.1007/s12325-019-01080-8. Epub 2019 Sep 4. PMID: 31485975; PMCID: PMC6822815.
[36] Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep 23; 390(10101):1550-1562. doi: 10.1016/S0140-6736(17)30703-1. Epub 2017 Mar 20. PMID: 28336049; PMCID: PMC6619426.
[37] Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003 Jun 26; 348(26):2646-55. doi: 10.1056/NEJMra021194. Erratum in: N Engl J Med. 2003 Aug 7; 349(6):620. PMID: 12826640.
[38] Knezevic J, Starchl C, Tmava Berisha A, Amrein K. Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? Nutrients. 2020 Jun 12; 12(6):1769. doi: 10.3390/nu12061769. PMID: 32545596; PMCID: PMC7353203.
[39] Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011 May 20; 332(6032):974-7. doi: 10. 1126/ science. 1206095. Epub 2011 Apr 21. PMID: 21512004; PMCID: PMC3164325.
[40] Li D, Cai W, Gu R, Zhang Y, Zhang H, Tang K, Xu P, Katirai F, Shi W, Wang L, Huang T, Huang B. Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients. Clin Immunol. 2013 Dec;149(3):411-20. doi: 10.1016/j.clim.2013.10.001. Epub 2013 Oct 11. PMID: 24211715.
[41] Fujii A, Inoue N, Watanabe M, Kawakami C, Hidaka Y, Hayashizaki Y, Iwatani Y. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease. Thyroid. 2017 Jan;27(1):111-119. doi: 10.1089/thy.2016.0345. Epub 2016 Nov 18. PMID: 27762730.
[42] Mizuma T, Watanabe M, Inoue N, Arakawa Y, Tomari S, Hidaka Y, Iwatani Y. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease. Autoimmunity. 2017 Sep;50(6):386-392. doi: 10.1080/08916934.2017.1344971. Epub 2017 Jul 4. PMID: 28675712.
[43] Lauritano EC, Bilotta AL, Gabrielli M, Scarpellini E, Lupascu A, Laginestra A, Novi M, Sottili S, Serricchio M, Cammarota G, Gasbarrini G, Pontecorvi A, Gasbarrini A. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007 Nov;92(11):4180-4. doi: 10.1210/jc.2007-0606. Epub 2007 Aug 14. PMID: 17698907.
[44] Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol. 2009 Jun 14; 15(22):2701-7. doi: 10.3748/wjg.15.2701. PMID: 19522019; PMCID: PMC2695884.
[45] Figura N, Di Cairano G, Lorè F, Guarino E, Gragnoli A, Cataldo D, Giannace R, Vaira D, Bianciardi L, Kristodhullu S, Lenzi C, Torricelli V, Orlandini G, Gennari C. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol. 1999 Dec;50(5):817-26. PMID: 10695561.
[46] Aghili R, Jafarzadeh F, Ghorbani R, Khamseh ME, Salami MA, Malek M. The association of Helicobacter pylori infection with Hashimoto's thyroiditis. Acta Med Iran. 2013 May 30; 51(5):293-6. PMID: 23737311.
[47] de Luis DA, Varela C, de La Calle H, Cantón R, de Argila CM, San Roman AL, Boixeda D. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol. 1998 Jun;26(4):259-63. doi: 10.1097/00004836-199806000-00008. PMID: 9649006.
[48] Spitzer M, Alexanian S, Farwell AP. Thyrotoxicosis with post-treatment hypothyroidism in a patient with acute suppurative thyroiditis due to porphyromonas. Thyroid. 2012 Jan;22(1):97-100. doi: 10.1089/thy.2011.0159. Epub 2011 Dec 2. PMID: 22136210.
[49] Larizza D, Calcaterra V, Martinetti M, Negrini R, De Silvestri A, Cisternino M, Iannone AM, Solcia E. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab. 2006 Jan;91(1):176-9. doi: 10. 1210/ jc. 2005-1272. Epub 2005 Nov 1. PMID: 16263823.
[50] Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord. 2016 Dec; 17(4):485-498. doi: 10.1007/s11154-016-9363-2. PMID: 27307072.
[51] Kiseleva EP, Mikhailopulo KI, Sviridov OV, Novik GI, Knirel YA, Szwajcer Dey E. The role of components of Bifidobacterium and Lactobacillus in pathogenesis and serologic diagnosis of autoimmune thyroid diseases. Benef Microbes. 2011 Jun;2(2):139-54. doi: 10.3920/BM2010.0011. PMID: 21831795.
[52] D'Elios MM, Bergman MP, Azzurri A, Amedei A, Benagiano M, De Pont JJ, Cianchi F, Vandenbroucke-Grauls CM, Romagnani S, Appelmelk BJ, Del Prete G. H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology. 2001 Feb;120(2):377-86. doi: 10.1053/gast.2001.21187. PMID: 11159878.
[53] Ajjan RA, Weetman AP. The Pathogenesis of Hashimoto's Thyroiditis: Further Developments in our Understanding. Horm Metab Res. 2015 Sep;47(10):702-10. doi: 10.1055/s-0035-1548832. Epub 2015 Apr 16. PMID: 26361257.
[54] Varbanova M, Frauenschläger K, Malfertheiner P. Chronic gastritis - an update. Best Pract Res Clin Gastroenterol. 2014 Dec;28(6):1031-42. doi: 10.1016/j.bpg.2014.10.005. Epub 2014 Oct 30. PMID: 25439069.
[55] Santaguida MG, Gatto I, Mangino G, Virili C, Stramazzo I, Fallahi P, Antonelli A, Segni M, Romeo G, Centanni M. BREG cells in Hashimoto's thyroiditis isolated or associated to further organ-specific autoimmune diseases. Clin Immunol. 2017 Nov;184:42-47. doi: 10.1016/j.clim.2017.04.012. Epub 2017 Apr 28. PMID: 28461108.
[56] Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C, Churilov LP, Ferrari SM, Antonelli A. Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019 Dec; 33(6):101367. doi: 10.1016/j.beem. 2019.101367. Epub 2019 Nov 26. PMID: 31812326.
[57] Alenghat T, Artis D. Epigenomic regulation of host-microbiota interactions. Trends Immunol. 2014 Nov; 35(11):518-25. doi: 10.1016/j.it.2014.09.007. Epub 2014 Oct 22. PMID: 25443494; PMCID: PMC4254645.
[58] Santaguida MG, Nardo S, Del Duca SC, Lococo E, Virili C, Gargano L, Lenti L, Centanni M. Increased interleukin-4-positive lymphocytes in patients with Hashimoto's thyroiditis and concurrent non-endocrine autoimmune disorders. Clin Exp Immunol. 2011 Aug;165(2):148-54. doi: 10.1111/j.1365-2249.2011.04419.x. Epub 2011 May 30. PMID: 21623768; PMCID: PMC3142639.
[59] De Maria R, Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today. 1998 Mar;19(3):121-5. doi: 10.1016/s0167-5699(97)01202-4. PMID: 9540271.

Downloads: 4578
Visits: 198442

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.